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ABSTRACT 
 
 
Microtia is a congenital malformation that is characterized by variation in severity and its 
association with other anomalies. Microtia may be a clinical sign of certain syndromes. A 
typical microtia patient has such a visible malformation that reconstructive surgery of the 
auricle is desired. In addition to the malformed auricle, both the ear canal and middle ear 
are usually anomalous causing considerable hearing impairment.  
 
This thesis identifies the characteristics of microtia in the Finnish population and detects 
the existence of familial (hereditary) microtia in Finland. The first learning curve study of 
reconstructive surgery for microtia is presented. In addition, we have studied the 
association between auricular malformations and orofacial clefts.  
The study population for phenotypic characterization consisted of 190 patients referred for 
reconstruction of the auricle. Of this population, 109 patients were involved in the 
hereditary study. The learning curve study is based on 51 microtia reconstructions. The 
study of auricular malformations and clefts includes 100 patients.  
 
These studies show that the characteristics of microtia in Finland are for the most part 
similar to other populations, but there is a high variation in prevalences in different 
populations. The overall global prevalence is around 2.1/10 000 births compared to 4.3/10 
000 in Finland. The proportion of familial microtia in the Finnish population is over 20% 
and the mode of inheritance seems to be autosomal dominant with incomplete 
penetrance. The learning curve for microtia reconstruction is long and this finding strongly 
suggests national centralization of treatment. Microtia seems to be the most common ear 
malformation in cleft patients. The prevalence of microtia increases as the severity of cleft 
lip increases. This trend was not present in patients with cleft palate only.  
 
Improvement in surgical techniques, the development of biocompatible reconstructive 
materials, and advances in audiological equipment and diagnostic imaging have improved 
the ways that a patient with microtia is examined and treated. 
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1. Introduction 
 
Microtia means small auricle. Although the term itself is relatively simple to comprehend, 
the clinical findings associated with microtia, hearing impairment, heredity and surgical 
reconstruction of the auricle or the middle ear are far more complex. The overall 
conception of the characteristics and the adequate treatment for this malformation will be 
brought forth in this thesis. 
 
A moderate amount of literature has been published on microtia. An early microtia 
classification done by H. Marx in 1926 is still in clinical use and is widely referred to in the 
literature (Marx, 1926). Since the 1950’s, the evolution of microtia reconstruction has been 
notable. The pioneering work by Tanzer was the starting point for the use of autogenous 
rib cartilage in the reconstruction of a malformed auricle (Tanzer, 1959). This method, 
though difficult to perform, is still the recommended and most popular way to reconstruct 
the auricle. In addition, developments in health technology have yielded artificial materials 
that can be successfully used in place of cartilage (Wellisz T, 1993; Reinisch et al. 2009). 
Over the past decade, the research in tissue engineering has been intensive (Van Osch et 
al. 2004; Kamil et al., 2004; Reiffel et al., 2013). Today, rib cartilage can be substituted 
with tissue engineered cartilage in the reconstruction of the auricle (Yanaga et al., 2009).  
 
The reconstruction of the malformed auricle is one important part in the treatment of a 
microtia patient. However, understanding and solving the possible associated 
malformations, heredity issues, and hearing problems are as much, if not even more, 
important.  
 
The prevalence of microtia has considerable variation (Luquetti et al., 2011). This variation 
may be partially a consequence of the way that artefacts are registered. The use of 
different classification systems and diverse manners of characterizing microtia patients 
may alter the definition of real or actual prevalence. Both the healthcare system and the 
environment are rather similar in Finland and Sweden. However, the birth prevalence of 
microtia is 2.4 / 10 000 in Sweden (Harris et al. 1996) and approximately 4.3 / 10 000 in 
Finland (Finnish Register of Congenital Malformations, 2006). The almost two-fold 
difference in prevalence between these two countries may come from register bias, but 
! 10!
may also come from heredity. Both the environmental factors and genes are likely to 
predispose these two populations to first and second branchial arch malformations and 
microtia. It is likely that there are also real differences in the global prevalence of microtia 
due to the variation in predisposition related factors. Single gene mutations causing 
isolated microtia have not been found, although microtia is related to many known single 
gene syndromes or disorders.  
 
External auditory canal atresia and middle ear anomalies are usually (80-90%) associated 
with microtia (Mayer et al. 1997; Llano-Rivas et al. 1999). Thus, the typical hearing loss is 
associated with hearing tresholds between 55 to 65 dB HL. The gross magnitude of 
sensorineural hearing loss in microtia is 3-5 % (Eavey, 1995; Carvalho et al., 1999). 
Hearing restoration surgery or the use of hearing aids can be considered obligatory in 
bilateral microtia, but is a debatable issue with regard to unilateral microtia.  
 
This thesis consists of four original studies and the first one describes the characteristics 
of microtia in Finland and compares it to other populations. The second study detects the 
pattern of inheritance of microtia in Finland and includes a comparison of the phenotypes 
between sporadic and familial patients. The reconstruction of the auricle is the topic of the 
third study. The use of rib cartilage as a frame for the auricle and the coverage of the 
frame by skin and fascial flaps is the method used in Finland. The learning curve for this 
kind of surgery and patient satisfaction with this laborious procedure were also 
researched. In the fourth study, the relationship between orofacial clefts and external ear 
malformations is examined. Both orofacial and ear structures are the derivatives of the first 
and second pharyngeal arches. We have a high volume register of up to 8200 patients at 
The Cleft and Craniofacial Centre at the Helsinki University Central Hospital. These factors 
motivated us to study the relationship between these anatomically close malformations. 
This is the first detailed and high volume study on this topic. 
 
It is believed that the new information on microtia we have found in these four studies is 
beneficial for professionals working with ear anomalies, microtia patients themselves and a 
microtia patient’s parents. In addition to the original research, central issues concerning 
the assessment and the treatment of a patient with microtia are gathered in this thesis.  
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2. Review of the literature 
 
2.1. The auricle 
 
“Large ears indicate long and successful life” (Chinese trad.). The possible explanation for 
this correlation is discussed at the end of this chapter. However, the functional purpose of 
the human auricle is debatable. In physiological studies, the auricle seems to amplify 
middle frequencies (2-4 kHz) and facilitate the localization of a sound source in three-
dimensional space (Hofman et al. 1998). 
 
The basic elements of the normal pinna are: 1. the lobulus inferiorly, 2. helix, scapha and 
antihelix with its cruses posterosuperiorly, 3. tragus, antitragus, concha and crus helicis as 
the atrium to the auditory meatus and 4. fossa triangularis between the cruses of the 
anthelix and the helix (Figure 1). The blood supply to the auricle comes via a. auricularis 
posterior (branching directly from a. carotis externa), branches of a. temporalis 
superficialis and a.occipitalis. All arteries are accompanied by corresponding veins 
(Jackson, 2002). 
 
Four cranial nerves (CN) are involved in the sensory innervation of the auricle: n. 
auriculotemporalis (mandibular branch of nervus trigeminalis, CN V) anteriorly, n. facialis 
(CN VII) posterosuperiorly, n. vagus (CN X) and n. glossopharyngeus (CN IX) in the 
conchal region, mastoid skin and external auditory canal. N. auricularis magnus and n. 
occipitalis minor from the cervical plexus innervate lobulus and submastoid area (Schünke 
et al., 2007). 
 
There are plenty of anthropometric studies on the auricle. By one year of age, ear length 
has reached roughly 75% of its adult size, and a width of 90% correspondingly. On 
average, ear width reaches its mature size in males at 7 years and in females at 6 years. 
On average, ear length reaches maturity in males at 13 years and in females at 12 years 
(Farkas et al. 1992). Ethnic group and sex seem to influence the size and growth of the 
auricle. The vertical length of the auricle increases throughout one’s life. Its estimated 
! 12!
velocity is 0.22 mm per year. Aging and gravity cause this increase (Heathcote, 1995; 
Alexander et al. 2011). 
 
  
Figure 1. The human auricle. 
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2.2. Embryology 
 
2.2.1. General concept 
 
During the late embryonic (gestational weeks 5-8) and early fetal (weeks 8-16) period the 
human appearance takes shape (Figure 2). The development of the head and neck is 
rapid and the essential and sensitive stages are over within 7 weeks. By week 12, ears 
and facial structures are established and the rest of the fetal period is for growth and 
maturation (Schoenwolf et al., 2009). 
 
 
 
 
Figure 2. The embryo measuring approximately 15 mm by the seventh gestational 
week. Forthcoming auricle is marked with red. (Illustration by Julius Niiniranta, 2013). 
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In humans, five pairs of pharyngeal (or branchial) arches start to form on gestational day 
22. On that day the first pharyngeal arch appears under the developing eye and by day 29, 
all pharyngeal arches are distinguishable. These tuberosities are like short sausages 
fused to each other. The outer recesses between the arches are called pharyngeal clefts 
and the inner recesses are called pharyngeal pouches. The first pharyngeal arch forms the 
permanent structure discussed below. The second pharyngeal arch grows rapidly during 
the 4th and 5th weeks and expands caudally covering the remaining three arches. Anterior  
fusion of the pharyngeal arches is completed by week 10. The derivatives of pharyngeal 
arches, clefts and pouches concerning the face and ears are detailed in Table 1. 
 
 
Embryologic origin Skeletal elements muscles 
1st pharyngeal arch Incus, malleus, maxilla, zygoma, 
squamous portion of temporal 
bone, mandible, auricle 
Temporalis, masseter, mylohyoid, 
anterior belly of digastric, tensor 
tympani, tensor veli palatini 
1st pharyngeal cleft External auditory meatus, external 
part of the tympanic membrane 
- 
1st pharyngeal pouch Middle ear cavity, Eustachian tube, 
mastoid air cells, internal part of 
the tympanic membrane 
- 
2nd pharyngeal arch Stapes, styloid process, lesser 
horns and upper rim of hyoid, 
auricle 
Muscles of facial expression, 
posterior belly of digastric, 
stylohyoid, stapedius 
 
 
 
Table 1. The fate of the first and second pharyngeal arch, the first 
pharyngeal cleft and pouch.!
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2.2.2 Embryology of the ear 
 
The ear is derived from multiple embryonic origins. The external and middle ear develop 
from the first and second pharyngeal arches and the cleft in between them. The first cleft 
forms the external acoustic meatus and the external part of the tympanic membrane. In 
addition, the first pharyngeal pouch is opposed to the cleft from inside and extends to build 
up the Eustachian tube and the middle ear mucosa. Each pharyngeal arch consists of a 
mesenchymal core that is lined on the outside with ectoderm and on the inside with 
entoderm. Apart from these structures, the inner ear develops separately from an 
ectodermal otic placode. This is important to recognize because this is the explanation for 
why the inner ear is normal in most microtia cases. Embryogenesis also explains why 
some degree of external ear canal and middle ear hypoplasia is very often related to 
microtia. The mammalian middle ear develops through cavitation of a neural crest mass. In 
a recent study, it has been shown that the epithelium derived from endodermal cells 
develops cilia, which are important to clearing pathogenic infections from the middle ear 
(Thompson and Tucker, 2013). These endodermal derived cells are located in the 
Eustachian tube and extend slightly beyond the eardrum. In the middle wall and attic, the 
mucosa is of neural crest origin and is non-ciliated. Thus, the middle ear mucosa is of dual 
origin. The auricle develops from six hillocks that appear on the outer (ectodermal) surface 
of the first and second auricular arches during the 5th gestational week. Anterior (or 
ventral) hillocks are derivatives of the first pharyngeal arch and are called tragus, helix and 
cymba concha. Posterior (or dorsal) hillocks are derivatives of the second pharyngeal arch 
and are called antihelix, antitragus and concha (Schoenwolf et al., 2009). These names 
indicate the eventual structures that they build up, though the exact contribution of each 
hillock still remains in doubt (Hunter et al. 2005) (Figure 3). 
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Figure 3. Rough and schematic illustration of faetal origin of the auricle. Green area originates 
from the first pharyngeal arch and red area originates from the second pharyngeal arch.  
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2.3. Microtia 
 
 
2.3.1. Definition 
 
Micro is a Greek word meaning small and otia means ear related status. Thus microtia 
means congenitally small auricle (pinna), with or without structural abnormalities. Anotia is 
an extreme case of microtia where no normal ear structures are present. There is a wide 
range in size and shape of the normal human ear and thus a slightly small ear without 
structural deviations should be distinguished from real microtia (Marx et al. 1926). Also 
minor dysplasias, such as cup ear, protruding ears, isolated tragal and lobular 
abnormalities are not considered to be microtia. 
 
 
2.3.2 Classification 
 
In order to characterise the severity of microtia, many grading systems have been 
developed. It would be important to have some uniform classification system in order to 
define diagnosis, standardize research results and to improve treatment protocols. 
 
Hermann Marx’s microtia classification, published in 1926, was the first and has been one 
of the most widely used. He designated three categories: grade I microtia is characterized 
by an abnormally small auricle with all identifiable landmarks, grade II microtia consists of 
an abnormal auricle without some identifiable landmarks, and grade III microtia is 
recognized only by a small auricular remnant. According to Marx’s original classification, 
the mildest form of microtia (Marx grade I) structural abnormality was not an obligatory 
criterion. In addition, the definition for the normal size of the auricle was imprecise. Anotia 
(Marx grade IV) was not included in the original classification (Marx et al. 1926). Marx 
microtia grades are presented in Figure 4. 
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In 1957, Finnish otolaryngologist Y. Meurman grouped microtia into four categories. Type 
I: the auricle is small and retains most of its normal structure (the external auditory meatus 
is usually present). Type II: the auricle is moderately anomalous and can be hook, S, or 
question mark shaped in appearance. Type III: the auricle is a rudimentary soft tissue 
structure with no cartilage. Type IV: anotia, where all auricular structures are absent. 
Meurman’s classification is more precise and comprehensive than Marx’s classification 
when distinguishing between a normal small ear and microtia, and when considering the 
most extreme cases of anotia (Meurman, 1957). 
 
In 2009, Hunter and co-authors provided a classification system for microtia. Their 
classification is a mixture of those done by Marx and Meurman, but as a new aspect they 
included the actual size of the auricle in the classification. The criterion for microtia is 
fulfilled if the median longitudinal length of the auricle is more than 2 SD below the mean 
(Hunter et al. 2005). 
 
Another aspect used to classify microtia is surgical planning. A rough allocation based on 
the lobulus or concha type microtia is a justifiable classification scheme because the 
surgical method is different with these two variations. The pioneer of modern microtia 
surgery, R.C. Tanzer, classified ear abnormalities based on the surgical approach. In his  
grading system, type 1 is anotia, type 2 is divided into a) microtia with auricular canal 
Figure 4. Microtia in order of severity, Marx’s grades I-IV. !
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atresia and b) without auricular canal atresia. Tanzer’s grading is not confined to microtia. 
In his types 3-5, hypoplasia of the middle or upper third of the auricle and prominent ear 
are also included (Tanzer, 1978). One of the ear reconstruction pioneers Satoru Nagata 
has adapted this classification according to the surgical approach to lobular type that 
corresponds to Marx III and small concha type that corresponds to Marx II. Additionally, 
small concha type microtia, anotia and atypical microtia are sorted out in his classification 
(Nagata, 2000). 
 
 
 
2.3.3. Birth defects 
 
Structural defects (congenital malformations, disruptions and dysplasias) are a major 
cause of infant mortality, childhood morbidity and long-term disability. They are a major 
cause of fetal and newborn death. To investigate and prevent the burden of birth defects, 
register-based surveillance programmes have been introduced. The aim of surveillance 
programmes is to provide epidemiologic information on congenital anomalies. This 
enables a warning system for new teratogenic exposures. In addition, international 
programmes can be utilized to evaluate the effectiveness of primary prevention and to 
assess the impact of prenatal screening (www.eurocat-network.eu/aboutus/whatiseurocat). 
 
The International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) is 
a voluntary non-profit international organization affiliated with the WHO. The organization 
was established in Helsinki in 1974. The Clearinghouse collects information on birth defect 
surveillance and research programs from around the world.(www.icbdsr.org) 
 
EUROCAT (European surveillance of congenital anomalies) can be considered a 
European WHO Collaborating Centre for the Clearinghouse. This population-based data is 
collected from 43 registries in 23 countries in Europe, including Finland. Live births, fetal 
deaths, still births, terminated pregnancies because of fetal anomaly following prenatal 
diagnosis are all included in the data. Overall more than 1.7 million births are surveyed per 
year covering almost 30 % of the European birth population (www.eurocat-network.eu) 
 
In addition to the Clearinghouse and EUROCAT, there are also other programs gathering 
data from national registers. 
! 20!
 
Most of the microtia surveillance programs are population-based (such as EUROCAT), 
where information is derived from birth defect registers and usually includes live and 
stillbirths. In addition, a few programs are hospital-based, where information is gathered 
from distinct hospitals rather than population registers. The advantage of a hospital based 
register is that more uniform inclusion and diagnostic criteria are used when assessing 
features of the disease or clinical condition. 
 
 
2.3.4. Prevalence 
 
Based on register studies, the overall global prevalence for microtia is  around 2.1/10 000 
(Luquetti et al. 2011). However, there is great variation among different registers. The 
highest reported prevalence is over 20 times higher than the lowest, ranging from 0.83 to 
17.4/10,000 births. Forrester and Merz (2005) reported that Far East Asians, Pacific 
Islanders and Filipinos have greater prevalence than Caucasians. Quito of Ecuador is 
exceptional, representing the highest prevalence, 17.4/ 10 000, as mentioned above 
(Castilla and Orioli, 1986). 
Variation in prevalence may sometimes partly result from methodological factors. In a 
recent review by Luquetti et al. (2011), it was observed that microtia prevalence was 
higher in hospital-based and active ascertainment surveillance programs. However, the 
difference between population and hospital register settings was insignificant and the 
prevalence rates can be compared with each other. Thus the range in the prevalence of 
microtia is so clear that it also refers to real differences and cannot be explained by 
methodological factors. Examples of the prevalence of microtia are presented in Table 2. 
 
Population  Prevalence of microtia per 10 000 
births 
Reference 
Central-East France 0.8 Harris et al 1996 
Sweden 2.4 Harris et al 1996 
Hawaii (USA) 3.8 Forrester&Merz 2005 
Texas (USA) 2.9 Canfield et al 2009 
Quito in Equador 17.4 Castilla et al 1986 
!
Table 2. Examples of the prevalence of microtia extracted from the literature. !
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2.3.5. Risk factors 
 
In population studies, many risk factors for microtia have been suggested. Both 
environmental and genetic factors may predispose to the occurrence of microtia. 
 
Drugs 
 
Drugs, such as retinoids, thalidomide and mycophenolate motefil (immunosuppressant) 
are known risk factors for microtia (Anderka et al., 2009). The exact mechanism is not 
known. Folic-acid intake during pregnancy seems to reduce the risk of microtia among 
non-obese women (Ma et al. 2010).  
 
Altitude 
 
High altitude may be a risk factor (Castilla et al. 1999). In high altitude cities such as Quito 
(altitude 2800 m), La Paz (3250-4100 m) and Bogota (2600 m) the prevalence of microtia 
is substantially higher than in other locations. Ethnicity and nutritional factors (i.e. 
agriculture at high altitudes) may confound these results. 
 
! 22!
 
 
Ethnicity 
 
Population studies performed in the United States report variations in prevalence 
according to race with a higher risk for individuals of Asian heritage, Pacific Islanders and 
individuals of Hispanic descent when compared to Caucasians and African-Americans. 
The ethnicity-based risk for microtia seems to be higher in isolated cases (Harris et al. 
1996; Shaw et al. 2004; Forrester and Merz, 2005; Canfield et al. 2009). Castilla et al. 
(1986) used data that is not solely population-based and reported higher microtia 
prevalence for Ecuadorians (Castilla and Orioli, 1986). These variations might be in part 
due to genetic variation, environmental factors or a combination of gene-environment 
interactions. 
 
Inheritance 
 
Estimations of familial microtia range from 3-34% (Mastroiacovo et al. 1995; Llano-Rivas 
et al. 1999). Both autosomal dominant and recessive traits have been described (Llano-
Rivas et al. 1999; Tasse et al. 2005). Tasse and co-authors reported a positive family 
history in 5/53 microtia patients. In addition, they reported that patients with familial 
disease are more often bilaterally affected (Tasse et al. 2005). 
 
Other risk factors 
 
In addition to race, drugs and high altitude, numerous risk factors have also been 
suggested. For example, male sex, low birthweight (<2500 g), first parity, high parity, high 
paternal age and low maternal education are mentioned as general risk factors (Castilla 
and Orioli, 1986; Mastroiacovo et al., 1995; Harris et al., 1996). 
 
 
 
2.3.6. Characteristics  
 
The severity of microtia varies greatly. The diversity of both grading systems and clinical 
assessment have impact on accuracy in evaluating microtia. Marx grade I may be over or 
! 23!
underdiagnosed, grades II+III are occasionally pooled and anotia is not always separately 
reported. Marx’s grades I and IV form minorities in most reports. In a well-designed and 
reported study by Mastroiacovo et al. (1995), the proportion of Marx grade I was 20 %, 
grade II-III was 60 % and grade IV was 20 % (Mastroiacovo et al. 1995). In two other 
reports, the proportion of anotia is considerably less at under 10% (Harris et al. 1996; 
Forrester and Merz, 2005). 
 
Most microtia cases are unilateral (79-91%) and there is a right-side dominance. 
Approximately 60% of unilateral microtia is right-sided. This is an exceedingly uniform 
observation in the literature and a definite explanation for this has not been reached. In 9-
21 % of patients, microtia is bilateral and some of these cases are asymmetrical 
(Mastroiacovo et al. 1995).  
 
In population studies, there is a clear male predominance for microtia. This predominance 
varies between 58-64% and cannot be explained by register-based artefacts. The reason 
for this higher prevalence amongst males remains unknown (Mastroiacovo et al. 1995; 
Harris et al. 1996; Okajima et al. 1996; Forrester and Merz, 2005). 
 
External auditory canal atresia is associated with microtia in 55-92 % of cases (Castilla 
and Orioli, 1986; Okajima et al. 1996; Llano rivas et al. 1999). Atresia means the absence 
of the ear canal. There is variation in the magnitude of the atresia. It can be mostly bony, 
constituting a very thick barrier, or it can be a relatively thin layer of soft tissue. Narrowing 
of the canal is called stenosis, which is seen (or reported) less often in association with 
microtia. High-resolution computed tomography (HRCT) is the best way to evaluate the 
status of atresia and the middle ear (Kountakis et al. 1995). In a Japanese study, there is 
highly significant correlation between microtia grade and external auditory canal existence 
(Table 3) (Ishimoto et al. 2005). 
 
Table 3. Correlation between microtia grade and external auditory canal atresia. N=142 
ears. 
  Marx I  Marx II  Marx III 
External auditory 
canal atretic,% 
42 67 91 
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The reported prevalence of syndromic microtia is 15-75 %. If no other anomalies are 
found, the microtia is interpreted as being “isolated” (Castilla and Orioli, 1986; Shaw et al. 
2004). The defects most frequently associated with microtia are mandibular hypoplasia, 
cardiac defects, orofacial clefts, facial nerve palsy, anophthalmia or microphthalmia, limb 
defects, urinary tract and kidney defects and brain anomalies (Celia et al. 1989; 
Mastroiacovo et al. 1995; Harris et al. 1996; Forrester and Merz, 2005). 
 
 
2.3.7. Syndromes 
 
Oculo-auriculo-vertebral spectrum (OAVS) is a cluster of clinical findings characterized by 
facial asymmetry, microtia, ear and facial skin tags, epibulbar dermoids in the eyes, 
microphthalmia, and occasionally macrostomia. Hemifacial microsomia (HFM) and 
Goldenhar syndrome can be considered to represent different degrees of this spectrum. 
OAVS is likely to have heterogeneous etiology and most cases seem to be sporadic, but 
familial cases have also been reported (Vendramini-Pittoli et al. 2009). Craniofacial 
findings of OAVS are thought to be caused by failure in the development of the first and 
second branchial arch derivatives (Tasse et al. 2005). Extracranial features include renal, 
cardiac, and vertebral anomalies (Digilio et al. 2008). Some authors classify isolated 
microtia as the mildest form of OAVS. Tasse et al. (2005) suggest that even a preauricular 
tag or pit in a family member of the microtia patient is a diagnostic basis for OAVS, as 
coincidental finding is unlikely.  
 
A syndrome can be defined as a combination of signs and symptoms that are indicative of 
a particular disease or disorder (Collin’s English Dictionary, 2003). Contrary to a 
syndrome, a spectrum is defined as a broad range of varied but related objects that form a 
continuous series or sequence (Random House Kernerman Webster's College Dictionary, 
2010). In the mildest form of OAVS there can be only one clinical finding, microtia (or 
preauricular tag/pit). On the other end of the spectrum, the most severe cases of OAVS 
(Goldenhar) fulfill the criteria for a syndrome. Thus spectrum is the most inclusive and 
applicable term to describe OAVS.  
 
In addition to OAVS, microtia is associated with a huge variety of rare syndromes. Roughly 
10% of microtia patients have a known syndrome (excluding OAVS that was discussed 
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above) (Harris et al. 1996; Forrester and Merz, 2005) of which Treacher Collins is perhaps 
the most widely known example. CHARGE, Nager, Klippel-Feil, Branchio-Oto-Renal 
syndrome are the other syndromes most frequently mentioned in the literature.  
 
 
 
2.3.8. Genetics 
 
There are no individual genes identified as causing isolated microtia. However, several 
genes have been identified as being associated with syndromic microtia. 
 
Homeoboxes (HOX) are DNA sequences that are associated with cell differentiation and 
are important in embryogenesis. In animal studies HOXA1, HOXA2 and HOXB1 are found 
to be involved in the development of craniofacial structures. Mutations in these genes may 
result in failure to form the neural crest cell streams needed in the development of the    
2nd pharyngeal arch. This in turn results in deficiencies in forming both 2nd arch and 
pouch derived tissues, as well as 1st arch and 3rd pouch derivatives (Rossel et al. 1999). 
In humans, inner ear malformations and deafness are frequently caused by HOXA1 
mutations, with external ear malformations being less frequent (Bosley et al. 2008). A 
mutation in the HOXA2 homeobox gene has recently been identified in an Iranian family 
with grade II microtia and partial palatal cleft (Alasti et al. 2009). 
 
Treacher Collins syndrome (TCS) is a craniofacial disorder that follows autosomal 
dominant inheritance. The TCOF1 (Treacher Collins-Franceschetti 1) gene encodes a 
protein called Treacle. In animal studies, the miscoding of Treacle has led to down-
regulation of neural crest cell proliferation and high level of apoptosis. A reduction of the 
number of these cells at a critical time in embryogenesis leads to the malformations typical 
for TCS. In about 80% of human patients, TCS is caused by heterozygous mutations of 
the TCOF1 gene. The phenotype typically includes bilateral microtia and hypoplasia of the 
facial bones, especially the mandible and zygomatic complex. In the eyes, downward 
slanting of the palpebral fissures with notching of the lower eyelids is also very typical. 
Palatal cleft is present in about 28% of cases. The phenotype varies, ranging from mild 
occasionally unaffected mutation carriers, to severe forms leading to intrauterine death 
(Dixon et al. 1991; Edwards et al. 1997; Trainor et al. 2009; Beygoa et al. 2011). 
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Branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized 
by branchial cleft abnormalities, otic developmental defects and renal malformations. The 
associated EYA1 (Eyes absent 1) gene codes the corresponding protein. EYA1 is required 
for normal pre-placodal ectoderm and placodal neuron formation. EYA1 mutations may 
result in malformation of the otic placode and inner ear dysfunction. External ear findings 
are mild, mostly prominent or cup ears (Li et al. 2010). Microtia as such has not been 
reported, but is suspected (Gupta and Patton, 1995). 
 
Mutations in the SALL1 (sal-like 1) gene may lead to the rare Townes-Brocks Syndrome 
(TBS) with anal, auricular and thumb malformations. External auricular anomalies in TBS 
typically include small ears with an overfolded superior helix and a small antihelix, with 
preauricular tags. Middle ear abnormalities are reported, but hearing loss is predominantly 
sensorineural (Powell and Michaelis, 1999). 
 
Chromosomal abnormalities associated with microtia are also detected, such as trisomy 
of chromosomes 13, 18 and 22. Rearrangements, microdeletions and hereditary genomic 
copy number variants have also been found along with microtia (Alasti and van Kamp, 
2009).  
 
 
 
2.4. Microtia, the middle ear and hearing 
 
 
2.4.1. Hearing impairment in microtia 
 
Conductive hearing loss  
 
External auditory canal atresia and middle ear anomalies are frequently (80-90%) 
associated with microtia causing conductive hearing loss in the affected ear (Llano-Rivas 
et al. 1999; Kelley and Scholes, 2007). If the ear canal is atretic, the soundwaves cannot 
enter the middle ear normally. On the other hand, the vibrating elements (the ear drum 
and ossicles) may be abnormal and soundwaves are hindered while entering the inner 
ear. Hearing evaluation with audiometry is an important part of assessing a patient with 
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microtia. Hearing tresholds are typically between 55-65 dB HL, while a normal level is 0-20 
dB HL. Ishimoto et al. (2007) evaluated the relationship between hearing level and 
temporal bone abnormalities in patients with microtia. As a conclusion, the hearing level in 
microtic ears correlated with the formation of oval/round windows and ossicular 
development, but not with the degree of middle ear aeration, or severity of microtia. Even 
mild microtia with mild external auditory canal stenosis can be associated with severe 
conductive hearing loss due to ossicular anomalies.  
 
 
Sensorineural hearing loss  
 
All of the inner ear derivatives build up from ectodermal otic placode and develop 
separately from the external and middle ear structures. Thus, the prevalence of 
sensorineural hearing loss (SNHL) is rather infrequent among microtia patients. In a series 
by Carvalho et al. (1999), SNHL was present in 11% of the children with hemifacial 
microsomia. It is significantly higher than the 0.1% to 0.4% incidence of congenital SNHL  
or the 3% to 4% incidence of sensorineural hearing loss seen in patients with other 
craniofacial syndromes (Carvalho et al. 1999). In two other studies, the proportion of SNHL 
among microtia patients was 3.4-5.6 % (Eavey, 1995; Llano-Rivas et al. 1999). Bisdas et 
al. studied inner ear abnormalities among 14 Goldenhar syndrome patients and found 5 
patients (36%) with sensorineural hearing loss (Bisdas et al. 2005). 
 
 
2.4.2. Middle ear findings in microtia and aural atresia 
 
The same embryological origin and timing during embryogenesis is a sensible explanation 
for coincidental malformation of the external and middle ear. The availability and accuracy 
of imaging, especially HRCT has made it possible to investigate middle ear findings 
among microtia patients. 
 
Mayer et al. (1997) studied 184 temporal bones of 92 children with microtia. They found 
that the malleus or incus were dysplastic in half of the cases among patients with microtia 
(Marx) grade I-II, and 98% of the Marx grade III patients. The stapes was dysplastic or 
absent in 52% of grade I-II patients and in 71% of grade III patients. The oval window was 
occluded in 36-41% of cases and there was no correlation with microtia grade. Middle ear 
! 28!
space is typically reduced in microtia. The course of the facial nerve may be abnormal. 
The tympanic segment may be located caudally and the mastoid segment may be located 
anteriorly compared to the normal course (Mayer et al. 1997; Ishimoto et al. 2005).  
 
 
2.4.3. Candidacy for hearing restoration surgery 
 
Jahrsdoerfer et al. (1992) published an important and widely cited report called “Grading 
system for the selection of patients with congenital aural atresia”. The goal of the grading 
system is to select those patients who have the greatest chance of success in atresia and 
middle ear surgery, where success is defined as a postoperative speech reception 
threshold of 15 to 25 dB HL. The grading scheme is based on the preoperative temporal 
bone CT scan and the appearance of the external ear. Patients get a score consisting of 
points between 1 and 10. The objects that correspond to the points are presented in Table 
4. 
 
Anatomical structure Score 
Stapes bone 2 
Oval window open 1 
Middle ear space 1 
Facial nerve 1 
Malleus-incus complex 1 
Mastoid pneumatization 1 
Incus-stapes connection 1 
Round window 1 
External ear 1 
Total  10 
 
 
Table 4. Grading Scale Score for Congenital Aural Atresia by 
Jahrsdoerfer et al. (1992). !
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The better developed the external ear, the better developed the middle ear. This is the 
conclusion made by Stilianos et al. (1995) when they analyzed 199 ears with microtia and 
aural atresia, and 25 patients with aural stenosis without microtia. The average 
Jahrsdoerfer atresia score was 8.5 with Marx grade I microtia, 7.2 with grade II microtia 
and 5.9 with grade III microtia. In cases with canal stenosis without microtia, the average 
atresia score was 8.3. 
 
To determine the predictive ability of the Jahrsdoerfer score in congenital aural atresia 
surgery, Shonka et al. (2008) evaluated 108 patients with aural atresia (116 ears). They 
compared the preoperative Jahrsdoerfer score (1-10 points) with the postoperative pure-
tone averages and speech reception thresholds. Ears scoring 6 or less had a 45% chance 
of achieving a postoperative speech reception threshold of 30 dB HL or better, while ears 
scoring 7 or higher had an 89% chance. They also found that lack of middle ear aeration 
was the only anatomical factor predictive of a poor audiometric outcome. They state that 
the Jahrsdoerfer grading scale is an invaluable tool in the preoperative evaluation of 
patients with congenital aural atresia (Shonka et al. 2008). 
 
 
 
2.4.4. Hearing aids and microtia 
 
The typical hearing impairment in microtia is conductive. The inner ear itself is usually 
normal. Thus an appropriate sound amplification technique gives good audiologic 
outcomes.  
 
 
Air conduction hearing aids 
 
If there is only stenosis of the external auditory canal, the conventional air conduction 
hearing aid may be usable if the required anatomy of the external ear is present. The two 
main divisions are behind-the ear (BTE) and in-the-ear (ITE) hearing aids. The fitting has 
to be made on an anatomic and audiologic basis. In the overall rehabilitation, concept a 
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patient’s hope for an ideal outcome also has to be considered (Essentials of Audiology, 
2009; Textbook of Audiological Medicine, 2011). 
 
 
Bone conduction hearing aids 
 
In most microtia patients, the external auditory canal is atretic and the anatomy of the 
pinna is so obscure that a conventional air conduction hearing aid cannot be used. As 
such, one of the three bone conduction hearing aid systems may be an option: 1. 
conventional: the bone conduction oscillator is compressed against the skin with a 
headband or with the earpiece of the patient’s eyeglasses, 2. transcutaneous: a magnetic 
plate is implanted in the temporal bone under the skin and a second magnet holds a 
transmitter in place on the outside of the skin, and 3. percutaneous: a titanium screw is 
fixed in the skull and it permanently penetrates the skin. An oscillator is then attached to 
the end of the screw (bone anchored hearing aid). The simplified structure of these 
devices includes a microphone, a sound amplifier and a transducer (bone conduction 
oscillator) (Paula et al. 2007). The microphone picks up the sound and converts the 
mechanical vibration into an electric signal and after modulation and amplification, the 
transducer converts the electric signal into bone vibration. 
 
 
Bone-anchored hearing aid 
 
The percutaneous model is also called bone-anchored hearing aid and is the most widely 
used apparatus among microtia/atresia patients. A percutaneously bone-anchored hearing 
aid has good compliance and audiologic results. The implantation site of the bone-
anchored hearing aid is the temporo-occipital bone behind the pinna. This is both 
cosmetically and audiologically an appropriate area. In children the limiting factor is often 
the thickness of dense cortical bone in the temporo-occipital region and patients that are 
less than two years of age have been held as contraindication (Textbook of Audiological 
Medicine, 2011). According to the FDA, bone-anchored hearing aid is specifically used for 
patients over five years of age in the United States. However, even 14 months old children 
have been successfully implanted with a bone-anchored hearing aid. Davids et al. (2007) 
studied 20 children under 5 years of age implanted with bone-anchored hearing aid and 
compared them to 20 implanted children older than 5 years. They conclude that 2-stage  
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implantation of bone-anchored hearing aid is safe and successful in younger children and 
has comparable audiologic outcomes and traumatic device failures and/or revisions to 
what is achieved in older children. There should be an appropriate delay between the 
titanium fixture implantation and the hearing-aid placement to allow for good 
osseointegration. 
 
A bone-anchored hearing aid has several advantages over other bone-conduction hearing 
aids, such as the elimination of audio feedback, headband pressure and the instability of 
vibrator positioning. Additional benefits include improvement in high-frequency response 
and reduced distortion. The complication rate is low and patient satisfaction is high among 
bone-anchored hearing aid users in general. (Dutt et al. 2002; Badran et al. 2006; Davids 
et al. 2007). 
 
Other hearing devices 
 
There are also other hearing devices suitable for microtia patients. Middle ear implants, 
such as a Vibrant Soundbridge® (Med-El), have given satisfactory results. The floating 
mass transducer (FMT) of this device can be attached to the long process of the incus or 
round window, where it converts electric signal into vibration. When planning for a middle 
ear implant, the status of the middle ear should be carefully examined with HRCT (Roman 
et al. 2012). 
 
New applications of old inventions are also introduced. Bonebridge™ (Med-El) is a 
transcutaneous implantable device, where an external audio processor is held in place 
directly above the implant by a magnet. The sound is converted into an electric signal, 
which is then transferred through the skin to the implant embedded in the temporal bone. 
The implant converts the signal into mechanical vibration, which is then conducted to the 
inner ear. Also, other devices based on bone conduction without a skin-penetrating 
abutment are available and have shown promising results in the pediatric population 
(Håkansson et al. 2008; Doshi et al. 2012). 
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2.5. Surgical reconstruction of microtia 
 
 
According to the literature, an Italian surgeon Tagliacozzi described and illustrated 
repairing ear deformities with skin flaps from behind the auricle as early as 1597 
(Tagliacozzi, 1597). The first mention of costal cartilage use in ear reconstruction is in 
1919. This publication by H. D. Gillies (1920) is mostly based on selected cases of war 
injuries of the face. Gillies also repaired over 30 microtic ears with rib cartilage harvested 
from the patient’s mother. These allografts were found to progressively resorb (Gillies, 
1937; Converse, 1977). 
 
 
2.5.1. Autologous costal cartilage reconstruction 
 
The established method of choice in microtia reconstruction is based on the autologous 
costal cartilage graft procedure introduced by RC Tanzer in 1959. His method has been 
the basis for the later and most widely used methods published by Burt Brent and Satoru 
Nagata (Tanzer, 1959; Brent, 1980; Brent, 1992; Nagata, 1993). 
 Brent has developed a reconstruction method consisting of 4 stages as follows: 1. 
harvesting the rib cartilage, sculpturing the pinna framework and inserting the cartilage 
beneath the auricular skin, 2. lobulus transposition, 3. elevation of the framework and 
covering of the posterior surface by a skin graft taken from the hip region and 4. tragus 
construction. The time interval between these stages is several months. 
Nagata uses a two-stage procedure in which the first stage involves the harvesting of the 
costal cartilage, the fabrication of the 3-dimensional frame and the insertion of the frame 
under the skin to its terminal position. The second stage consists of the elevation of the 
pinna and the insertion of a cartilage block to support this protrusion. Instead of a free skin 
graft, Nagata uses a split-thickness temporoparietal fascia flap to cover the exposed 
posterior area of the pinna (Nagata, 1993). In addition to Brent and Nagata, many other 
surgeons have made several modifications of these operative techniques. 
 
The appropriate age for microtia reconstruction varies, but certain physical and 
psychological factors should be considered. There is usually sufficient rib cartilage 
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available for reconstruction by the age of six if the surgeon uses the Brent technique. The 
patient should be aware of the problems and the surgical solution and thus be prepared for 
good co-operation. The most typical age to begin the surgery is 6-7 years for Brent (Brent, 
1992). The auricle has almost reached adult size around 10 years of age. In Japan 10 
year is the recommended age to start the surgery. The amount of costal cartilage in the 
Nagata technique should be sufficient at that age (Nagata in the book: Plastic Surgery: 
Indications, Operations, and Outcome, 2000). As live tissue, a reconstructed ear will 
propably grow after the implantation (DellaCroce, 2001). 
 
 
2.5.2. Alloplastic reconstruction 
 
In addition to autologous materials, alloplastic materials have also been used in auricular 
frameworks. 
 
Silicone seems like an ideal material for auricular reconstruction. However, it is too 
sensitive for minor traumas, causing skin erosion, necrosis and extrusions of the frame. 
Thus, the use of silicone for auricular frameworks has been abandoned. 
 
A high-density porous polyethylene framework (Medpor®) has been used for 20 years in 
ear reconstruction. With improved implant design and complete coverage of the implant 
with adequate skin and fascia flaps, the complication rate has diminished and long-term 
results are acceptable (Romo 3rd and Reitzen, 2008; Reinish and Levin, 2009). In addition 
to the auricle, Medpor® is widely used in the craniofacial area, such as the nose, maxilla 
and orbita (Cenzi et al. 2005). The porous material becomes vascularized and collagen is 
deposited on the surfaces. Porous polyethylene may provoke inflammation, but according 
to the literature the major complication rate is acceptable and equals that of costal 
cartilage reconstruction. Donor site morbidity, such as pain and a visible skin scar are 
avoided by using alloplastic material. With synthetic material, surgical time may be 
reduced and material fabrication is easier and more standardized. Some clinics prefer 
costal cartilage, while others accept synthetic materials, mainly Medpor®, as a good 
alternative (Williams et al. 1997; Zhao et al. 2009). Prospective studies, with independent 
evaluation of the results could not be found. 
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2.5.3. Ear epithesis 
 
A missing auricle or part of the auricle can be substituted by a prosthesis (epithesis). The 
prosthesis is not an intracorporeal implant and it is not vulnerable to bioincompatibility 
factors. Thus, the materials of the prosthesis can be chosen on the basis of manageability 
and durability. Silicone, acrylate compounds and polyurethane are the commonly used 
materials. Silicone is the main corpus of the prosthesis and other materials are added to 
give support for the integration and coating that enhances durability. Ear prostheses can 
be attached by adhesives or titanium osseo-integrated implants. The adhesives may be 
troublesome in a hot and humid climate, when the patient has an oily skin type and when 
there is a lot of hair in the area of installment. Titanium implants require surgery and follow 
up. The lifespan of the prosthesis is currently a few years due to color fading, delamination 
of the lining and possible accidental cracks. One advantage of a prosthetic ear is a good 
anatomic replication of the normal ear. Surgery is rather straightforward: it is single-stage 
and the complication rate is small (Tollefson, 2006; Wagenblast et al., 2008; Fini et al., 
2011).  
 
An important decision to be made is whether to reconstruct an ear with cartilage or implant 
an epithesis. Unsuccessful ear reconstruction with cartilage graft can almost always be 
converted into a prosthesis repair (Katzbach et al. 2006). However, osseo-integration of 
the titanium bridge for ear epithesis causes scarring and may hinder future reconstruction 
with cartilage and skin/fascia flaps. In treatment centers with extensive experience in rib 
cartilage ear reconstruction, a prosthesis implantation with osseo-integration is often only a 
secondary choice (Thorne et al. 2001). 
 
Westin et al. (2009) studied the safety and quality of osseointegrated epitheses. Ninety-
nine Swedish patients, of which 8 were bilateral (107 prosthetic ears), were followed for a 
period ranging from 1 to 12 years. The incidence of significant skin reaction was only 3%. 
They concluded that the surgical technique for auricular prostheses is simple and is 
associated with a low rate of perioperative and late complications. Aesthetic satisfaction 
was high and 95% of the patients were wearing their prosthesis every day, in most cases 
over 10 hours per day.  
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2.5.4. Tissue-engineering 
 
Tissue engineering aims to use a combination of living cells, engineered materials, and 
suitable biochemical factors to produce biological materials that are used to replace 
missing or damaged tissues. As an example, cartilage cells harvested from the auricle can 
be cultured in an appropriate cell culture media with growth factors and be supported by 
an ear shaped biocompatible polymer scaffold.  
 
Kamil et al. (2004) succeeded in creating a tissue-engineered human-sized auricle of 
normal anatomic definition in an immunocompetent animal model using a mold technique. 
Mixtures of autogenous chondrocytes and biodegradable polymers were used inside a 
perforated, auricle shaped hollow gold mold. These molds were implanted subcutaneously 
in the abdominal area of 10 animals (pigs and sheeps). The constructs were then removed 
after 8 to 20 weeks for a gross morphology and histology analysis. They concluded that 
the technique appears promising for potential use in patients with microtia. 
 
In a recent study by Reiffel et al. (2013), three-dimensional (3D) photogrammetry was 
utilized to create a copy of the human auricle. This 3D mold was then copied and filled 
with bovine chondrocytes, culturing media and a collagen type I scaffold. After a few days 
of culturing, these constructs were implanted in the dorsum of athymic nude mice. The 
implantation constructs were harvested and surveyed 1 to 3 months later. The histological 
and biomechanical properties were examined. As a conclusion, they created a 
biocompatible and anatomically patient-specific construct with appropriate biomechanical 
properties. Before the use of patient-specific chondrocytes or mesenchymal stem cells can 
be in clinical use, a lot of research has to be done. In their study, the new findings 
established that the use of 3D photogrammetry and collagen type I as a scaffold material 
was a promising development. 
 
Yanaga et al. (2009) have developed a multilayer chondrocyte culture technique and have 
successfully generated human ears. In their culture system, fibroblast growth factor-2 
(FGF2) has been added to the culture medium to make cells multiply and expand. In two-
stage implantation, the cultured chondrocytes are injection-implanted into the lower 
abdomen of the patient, where the cells grow into a larger cartilage block in 6 months. This 
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grown and matured cartilage is harvested surgically. Thereafter it can be sculptured into 
an auricular framework and be used the same way as the costal cartilage. In the first 
series they reported auricular reconstruction for four microtia patients using this technique 
(Yanaga et al. 2009). In a recent report, Yanaga et al. (2012) explained their culturing and 
implantation method in more detail. When the multilayered chondrocytes are transplanted 
into the abdominal subcutaneous tissue, the neocartilage and neoperichondrium of elastic 
cartilage origin are regenerated within 6 months after the transplantation. In dynamic 
measurements, the regenerated cartilage had the same viscoelasticity as normal auricular 
cartilage. So far, 12 microtia patients have been implanted with an auricular framework 
made of tissue-engineered neocartilage. In the 6 year period of postoperative monitoring, 
the neocartilage has maintained a good shape. No absorption has been noticed. They 
suppose that this culturing and implanting technique can have many applications in 
reconstructive and craniofacial surgery where cartilage is needed as a support or defect 
substitute (Yanaga et al. 2012). 
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3. Aims of the study 
 
 
 
1. Characterization of microtia in the Finnish population and comparisons to other 
populations. 
 
2. To study the inheritance of microtia in the Finnish population and compare possible 
phenotypic differences between sporadic and familial microtia patients. 
 
3. Analysis of the learning curve and patient satisfaction with reconstructive surgery 
for microtia. 
 
4. Detection of correlations between auricular malformations and cleft lip and/or palate 
in Finnish cleft patients. !
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4. Materials and methods 
 
 
This thesis constitutes an entirety that assesses and discusses microtia in the Finnish 
population and as a medical condition in general. The characterization, inheritance and 
surgical treatment of microtia are reported in three (I-III) original studies. The association 
of microtia and other external ear malformations with orofacial clefting is the main focus of 
the fourth original paper (IV). In this section, the general design and implementation of 
each study are explained. The Roman numerals in the brackets (I-IV) indicate a 
connection to a particular study. 
 
 
4.1. Patients 
 
The first step was to evaluate the clinical data of 200 microtia patients referred to the Cleft 
and Craniofacial Center of the Department of Plastic Surgery at Helsinki University Central 
Hospital between 1980-2005. In order to study isolated microtia, patients with 
chromosomal abnormalities and syndromic patients were excluded, thus leaving us with 
190 microtia patients. Hospital records from the Cleft and Craniofacial Center and central 
hospitals in Finland for 190 patients, facial photographs for 162 patients and audiograms 
for 70 patients constituted the data used for analysis.  
 
A detailed questionnaire was sent to all 190 patients. It concerned questions on physical 
and mental health, number of relatives, birthplaces of grandparents/parents, relatives with 
microtia or other malformations of the facial or auricular region. 109 patients (or parents) 
(57%) replied to the questionnaire. The hospital records and patient questionnaire derived 
data constituted the basis for studies I and II. 
 
The inclusion criteria for the third (III) study were: unilateral, non-syndromic, Marx grade III 
(lobulus type) microtia. In addition, postoperative photographs were essential because 
surgical results were assessed by a panel and by patients themselves. All auricular 
reconstructions were performed by a single surgeon. Following these criteria, the study 
population consisted of 51 patients with a reconstructed auricle. The majority of these 51 
patients are also included in the studies I and II. 
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The vast majority of the treatment of patients with cleft lip or cleft palate in Finland is 
centralized in the Cleft and Craniofacial Centre at the Helsinki University Central Hospital. 
As well, the majority of patients with other craniofacial malformations, including ears, are 
treated and examined in this institution. 
 
The Cleft and Craniofacial Centre at the Helsinki University Central Hospital has collected 
prospective data on cleft patients since 1995 and retrospective data since 1950. From this 
register consisting of almost 8200 cleft patients, we searched for all patients with an 
external ear malformation and either cleft lip with or without cleft palate (CL±P) or cleft 
palate (CP). The hospital records were examined and altogether 100 patients were 
identified for further analyses in the fourth (IV) study. 66 patients had CP and 34 CL+/-P. 
There were 43 cleft patients with microtia and unlike in studies I-III, syndromic patients 
were also included. Other 57 patient had preauricular skin tags, prominent ears or 
miscellaneous ear malformation. 
 
 
4.2. Study design 
 
The 190 microtia patients were assessed for laterality, sex distribution, aural atresia or 
stenosis, and preauricular sinuses or tags. The hearing results for these patients were also 
registered. Patients were also classified according to Marx’s and Tasse’s classifications 
and the results of the classification scores were compared to identify correlation between 
these classification systems. 
 
The Finnish Register of Congenital Malformations (RCM) was the source for identifying the 
prevalence, laterality and sex distribution of microtia in the Finnish population in general. 
The register is national and population-based. Stillbirths of 22 weeks of gestation or 500 g 
or more are registered. Statistics from 1993 to 2005, consisting of 771 425 births, were 
available to our study.  
The information obtained from RCM was compared to the other population based register 
reports based on literature searches (I). 
 
We surveyed individuals who reported a relative with microtia or preauricular tag. These 
individuals were classified as representing familial microtia (n=22). The phenotypic data of 
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these familial cases was compared against patients with no known relatives with microtia 
or preauricular tags (n=80). All the familial patients (or parents) were telephone 
interviewed. Familial patients (or parents) were also asked about the birthplace of their 
grandparents to identify regional clustering and a possible founder effect. If the birthplace 
of the grandparents were not known, parents were used instead (II). 
 
The outcome of the microtia reconstruction was evaluated by the panel made up of three 
ear, nose and throat specialists and three reconstructive surgeons. Postoperative 
photographs (Figure 5) were shown to the panel in randomized, nonchronologic order and 
six panel members assessed the result using a scale of 1 to 10. The ratings of the panel 
were merged to generate the learning curve of a single reconstructive surgeon (III). In 
addition to the panel, 22 patients responded to a questionnaire based on their feelings 
about their reconstructed ear on a scale of 1 to 10. These patients formed the self-
assessment group. 
 
In the study concerning clefts and ear malformations (IV), we collected data concerning 
gender, birthplace, birthweight and length, gestational weeks, gestation problems, type of 
cleft, site of cleft, type and severity of ear malformation, audiometrics, imaging, 
chromosomal analyses, other anomalies or diseases, cleft operations, number of siblings, 
and anomalies among family members. Facial or lateral photographs of 62/100 patients 
were available for the analysis. According to the severity of the cleft, patients were divided 
into the subgroups: 1. CL+/-P: cleft lip, cleft lip and alveolus, cleft lip and palate, 2. CP: soft 
palate, soft and hard palate, submucous palatal cleft. 
 
 
4.3. Statistical methods 
 
The independent samples t-test is used to compare the means of two independent 
samples. In particular, it was used in the comparison of the phenotypes of familial and 
sporadic microtia patients (II). 
 
To test whether independently chosen panel members are sufficiently able to form a 
reliable assessment group, intraclass correlations (ICC) were calculated (Shrout et al. 
1979) (III). The panel results were plotted and moving averages were calculated. In 
addition, these panel results were split into 5 groups, the mean and the variability of each 
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group was calculated. The analysis was done by repeated measures ANOVA (III). A 
paired t-test was used to compare the self-assessment group and the panel. A two-sample 
test was used to evaluate the influence of age and gender on the self-assessment group 
(III). Cross-tabling and chi-square tests were used in the comparison of the external ear 
anomalies and orofacial clefts (IV). 
 
 
4.4 Ethical perspectives 
 
All the studies were approved by the Ethics Committee of the Helsinki University Central 
Hospital. 
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Figure 5. Example of the postoperative photographs assessed by the panel.  
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5. Results 
 
5.1. Characterization of microtia (I) 
 
 
5.1.1. Hospital and patient based characteristics 
 
 The severity of microtia was classified according to Marx and the proportions were: Marx 
grade I (8.4%), grade II (32.5%), grade III (57.6%) and grade IV (1.5%). The median birth 
weight was 3450 g (range 2050—4600 g, average 3459 g) and the median gestational age 
was 40 weeks (range 33—42, average 39.6 weeks). 4.6% of children were born preterm 
and 2.8% had a birth weight of under 2500 g. Congenital heart defects were present in 
10.9% and 4.6% had anomalies of the extremities. 23% reported skeletal abnormalities, 
with scoliosis being the most frequently present. The patients spoke their first single words 
at the mean age of 13.2 months (range 6-36 months), and they walked unaided at the 
mean age of 12.2 months (range 8-54 months). A psychomotor developmental delay was 
reported to be present in 5.5% of the patients. The main characteristics are summarized in 
Table 5.  
 
Adequate audiometric data was available for 70 patients. Conductive hearing loss was 
present in 96.1% and sensorineural hearing loss was found in 9.0% of the affected ears.   
All ears with normal auricles had normal hearing. The detailed hearing results are 
presented in Table 6. 
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Table 5. The patient based characteristics of Finnish microtia patients. 
 
N 190 
Sex 58 % male 
Unilateral 88.4 % 
Bilateral 11.6 % 
Side of the defect 59.5 % right 
Aural atresia or stenosis 93 % 
Preuaricular sinus/tag 33.5 % (22.2 % ipsi, 7.2% contra and 4.2 % bilateral) 
Conductive 96.1 % Hearing loss in the 
affected ear Sensorineural 9.0 % 
 
 
Table 6. Hearing loss (PTA) in the affected ears. Classification by the American Speech-
Language-Hearing Association. PTA = average hearing threshold for pure tones at 0.5, 1, 
2 and 4 kHz. 
 
Degree of hearing loss (dB HL) Proportion % 
Normal to slightly disabled 
hearing (0-25) 
3.9 
Mild (26-40) 1.3 
Moderate (41-55) 13.2 
Moderate-severe (56-70) 59.2 
Severe (71-90) 21.1 
Profound (91 and more) 1.3 
 
 
 
5.1.2. Population-based results 
 
Data obtained from the Finnish Register for Congenital Malformations included 335 
microtia patients among 771 425 births (live + stillbirths). This corresponds to a prevalence 
of 4.3/10 000. Detailed register data is presented in Table 7. 
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Table 7. Population-based characteristics of microtia in Finland. 
Prevalence 4.3 / 10 000 
Sex 60.9 % male 
Unilateral 84.8 % 
Bilateral 9.0 % 
Side of the defect 63  % right 
 
 
 
5.2 Inheritance of microtia (II) 
 
Twenty-two patients of out of 109 had a relative with microtia or a preauricular tag. These 
patients were classified as familial. In addition, seven patients reported relatives with other 
craniofacial deformities. No regional clustering indicating a founder effect was detected 
when the birthplaces of parents or grandparents were analyzed. The proportion of familial 
microtia was 22/102 (approximately 22 %). The pattern of inheritance seemed to be 
autosomal dominant with incomplete penetrance. 
 
One-hundred and two (102) patients were included for phenotypic comparison. The 
familial and sporadic patients did not differ in gestational age, birth weight, psychomotor 
development, sex distribution or laterality of the affected ear. There was no difference in 
problems during pregnancy. Scoliosis or congenital heart problems were equally present 
in both groups. The distribution of the severity of microtia based on Marx classification was 
relatively equal. Urinary system anomalies were statistically more prevalent among familial 
patients (p< 0.01).  
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5.3. Reconstructive surgery for microtia  (III) 
 
The objective was to create a learning curve for a single surgeon performing microtia 
reconstruction. The results were assessed by a panel consisting of six physicians and a 
self-assessment group of 22 patients. 
 
To test the reliability of the assessment panel, the intraclass correlation (ICC) was 
calculated. The ICC addresses the uniformity of the panel. The ICC for three ENT 
specialists was 0.75 and it was 0.86 for the three plastic surgeons. The ICC for all six was 
0.90. The target level is 0.80 and thus the reliability of the assessment panel can be 
considered to be high in this study. 
 
The average number of assessment points given by the self-assessment group was 6.91 
and the average number of assessment points given by the panel was 6.59 (scale 1-10). 
This difference was statistically insignificant. Postoperative patient satisfaction was also 
evaluated. Females seemed to be more critical (n=6, range 1.0-8.0, mean 5.2, median 5) 
than males ( n=16, range 5-10, mean 7.6, median 8). This difference is statistically 
significant (p mean = 0.014, p median = 0.025). Patients who were operated under 10 and 
over 13 years of age did not have a statistically significant difference in their assessment 
points. 
 
The learning curve of microtia surgery was studied. A single surgeon performed 51 
auricular reconstructions. The learning curve created by 51 consecutive moving averages 
is demonstrated in Figure 6. The moving average is the mean of consecutive means. In 
this study, five consecutive means were calculated. The moving average smooths out high 
fluctuation and makes the visual interpretation of the results easier. 
 
In addition to the moving average, 51 patients were split into 5 groups of ten (11 in the last 
group). The mean number of points in each group was calculated and the results are 
presented in Table 8. There was a highly significant increasing trend in learning (p= 
0.000001). This learning trend did not rise constantly. Some improvement was still going 
on between the last two groups. 
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Figure 6. An example of the learning curve consisting of a continuum 
of 5 consecutive means for points given by the assessment panel. !
Patient number!
Po
in
ts
!
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Group No Mean of points ( SE 0.20) 
1 4.95 
2 6.83 
3 6.25 
4 6.08 
5 7.41 
 
Table 8. The mean number of points for groups 
assessed by the panel. !
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5.4. The relationships of cleft lip and/or palate and auricular malformations (IV) 
 
 
Auricular malformations of one hundred patients with cleft lip or palate were studied. The 
proportion of cleft palate (CP) was 66 % and cleft lip+/-palate (CL+/-P) was 34 %. There 
was no difference in sex distribution between these groups and this is consistent with the 
whole Finnish cleft register. There were 48 males and 52 females in the study group. 
 
The ear malformation was bilateral in 47 % (31/66) of the CP patients and 35 % (12/34) of 
the CL+/-P patients. Cleft lip and unilateral ear malformation occurred on the ipsilateral 
side in 88% (30/34) of the patients and on the contralateral side in 12% (4/34) of the 
patients. In 45/100 cases (45%) the combination of cleft and ear malformation was related 
to a syndrome. 
 
Microtia is almost equally prevalent in both CP and CL+/-P. Skin tags seem to be 
associated with CL (Figure 7) and especially with CL+/-A (cleft lip with or without cleft 
alveolus). Prominent ears seem to be associated with isolated CP (Figure 8). The 
prevalence of microtia seems to increase with the severity of CL+/-P, but there is not a 
similar association between microtia and CP (Figures 9 and 10). In addition to microtia, 
skin tag and prominent ears, there were 19 miscellaneous ear malformations, such as 
macrotia, malposition of the pinna, missing lobulus or cup ear. 
 
The combination of microtia and cleft lip +/- cleft palate was frequently found in both oculo-
auriculo-vertebral sequence (OAVS) and Treacher Collins syndrome (TCS). In OAVS, CP 
is slightly more common than CL+/-P. Of the seven Treacher Collins patients, six had CP 
and only one patient had cleft lip. 
 
Also other known syndromes were represented in the study population including 22q11.2 
deletion syndrome (CATCH22), Klippel-Feil, Pallister-Killian, Pierre Robin sequence, FAS 
and Turner. In addition, a few patients with syndromic features without definitive diagnosis 
were included. 
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Figure 7. Proportion (%) of skin tags among all cleft patients (N=100).  
 
 
 
 
Figure 8. Proportion (%) of prominent ears among all cleft patients (N=100). 
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Figure 9. Proportion (%) of microtia among cleft lip patients (N=34). 
 
 
 
 
Figure 10. Proportion (%) of microtia among cleft palate patients (N=66). 
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6. Discussion 
 
 
The treatment and careful inspection of a patient with microtia is beneficial. A 
reconstructive surgeon, an otologist, a pediatrician, a genetic counselor, an audiologist, an 
orthodontist and a psychological counselor are all often needed at different stages of the 
treatment. The treatment varies globally because economic conditions, health care 
arrangements, attitudes and agreed-on habits have influence on how medical conditions 
are taken care of. Non-life-threatening and rare diseases are not given special focus when 
resources in health care are allocated. Therefore, applied and basic research are the 
imperative foundation for decision making. 
 
We have probably 1000-2000 microtia patients in Finland with the total population of 5.4 
million. The treatment of microtia and associated conditions is emphasized during the first 
two decades of life and approximately 400 microtia patients are actively in a follow-up 
situation. Increased knowledge gives health care professionals and patients better tools to 
cope with this congenital condition. The target is to establish adequate practices for the 
treatment and examination of the microtia patient. 
 
The population in Finland is relatively small and has been genetically isolated. This has led 
to unique genetic characteristics. An example is the Finnish disease heritage: some 
genetic diseases are only found in Finland and conversely, diseases that are rather 
common in other parts of the world are not found in Finland. In addition to inherited 
diseases, this random genetic drift is likely to have an effect on the special features of 
genotypes and diseases in the Finnish population. Thus, the characteristics of 
malformations reported abroad cannot be compared directly to Finland. 
 
Our aim was to define the overall picture of microtia in Finland. Characterization, heredity, 
surgical treatment and its outcomes, and the association of auricular malformations with 
orofacial clefts were the focused areas of interest in this thesis. In addition, treatment 
options for auricular reconstruction, hearing restoration surgery, audiological aspects and 
the role of imaging are discussed.  
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6.1. Characteristics of microtia 
 
 
6.1.1 Patient-based studies 
 
Patient-based studies on the characteristics of microtia are numerous. The number of 
patients in these studies range from 53 (Tasse et al., 2005) to 592 (Okajima et al., 1996). 
This range of study size seems to be sufficient enough to define the integral features of 
microtia. State of the art imaging, particularly HRCT, has also specified the overall 
assessment of microtia. (Calzolari et al. 1999, Takegoshi and Kaga, 2003). 
 
All 190 patients in our study concerning the characterization of microtia were referred for 
surgical correction of the auricle. This probably results in underreporting of the mildest 
forms of microtia. Also an unknown but probably rather small number of patients may in 
addition from microtia suffer from other more severe conditions and are never even 
referred to the reconstructive surgeon. This might be the case particularly in syndromes 
with profound phenotypic expression. It is supposed that neither our patient material nor 
the other patient-based reports represent the true characteristics of microtia in the general 
population. However, this information can be utilized in planning treatment protocols and 
multi-professional approaches. 
 
In our study based on hospital records, male predominance (58%) and right-sidedness 
(59.5%) are in concordance with most hospital patient-based studies (Eavey et al., 1995; 
Okajima et al., 1996; Llano-Rivas et al. 1999). These features are supposed to be true 
because they are consistently present in the literature. The explanation for these 
manifestations is not clear. Twenty-two (11.5%) of the patients in our study had bilateral 
microtia with varying severity and asymmetry. In the literature, the range is from 9.1% 
(Okajima et al., 1996) to 50.9% (Tasse et al., 2005). In the latter report, skin tag on one 
side and microtia on the other side was classified as bilateral. In our material, microtia was 
associated with atresia or stenosis of the external auditory canal in 93% of cases. 
According to the literature, atresia is associated with microtia in 55-92% of cases (Llano-
Rivas et al.1999, Okajima et al. 1996, Castilla et al. 1986). There are also reports without 
comments on atresia or stenosis of the external auditory canal and only a few reports 
focusing on the degree of atresia (Kountakis et al. 1995, Ishimoto et al. 2005).  
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In our study, patient questionnaires concerning physical health were replied to by 109 
patients (or their parents). This data obtained through self-reporting should be interpreted 
with caution. The incidence of preterm (2.8%) and low birth weight (4.6%) in our material 
was not significantly higher than in the Finnish population in general (preterm 5.8% and 
low birth weight 4.4%). Structural heart defects were seen in more than 10% of our 
patients. Thus, the possibility of cardiovascular malformations should be remembered 
when examining a child with microtia. 
 
 
6.1.2 Population-based register studies 
 
There are several population-based registers providing epidemiologic information on 
congenital anomalies. The variation in classification systems, assessment, nomenclature 
and reporting of microtia sets up challenges for the precise characterization of microtia. 
Luquetti et al. (2011) debated these challenges comprehensively. They evaluated 92 
surveillance programs covering almost 9 000 cases of microtia-anotia. They state in their 
review that existing data on the prevalence of microtia should be examined critically. In 
addition, they hope for a coding system that enables complete phenotype characterization 
of microtia, including severity and laterality. 
 
The high variation in birth prevalence of microtia ranging from approximately 0.8-17.4 / 10 
000 births can be partly due to the registration artefacts. However, the twenty-fold 
difference is so huge that it is likely to be caused by real biological factors (environmental 
and genetic). In populations living at high altitudes, the birth prevalence of microtia is 
substantially higher than in general. In Quito, La Paz and Bogota, which are located 
between 2600-4100 m above sea level, the prevalence of microtia, oral clefts, heart 
defects and limb defects were higher than at lower living areas (Castilla et al. 1999, 
González-Andrade et al. 2010). High altitude is one factor that those defects have in 
common, but nutrition may be unique at higher altitudes and ethnicity may bring bias as 
well. There is no clear evidence that high altitude is an independent cause of microtia. 
 
The prevalence of microtia is 2.35/10 000 births in Sweden (Harris et al. 1996) and 
4.34/10 000 births in Finland. The environmental factors are rather similar in both 
countries, but heredity is likely to be different. The prevalence of microtia in Finland may 
be two times higher than the global overall prevalence, which is 2.06/10 000. The 
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assessment of microtia patients and other factors mentioned above challenge the reasons 
and exactness of these findings. As we were not able to analyse the actual cases in the 
register there may be overreporting by physicians not familiar with auricular deformities 
and the numbers obtained from Finnish Malformation Register have to be treated with 
caution. 
 
 
6.2 Inheritance of microtia 
 
In our study on the inheritance of non-syndromic microtia in the Finnish population, we 
concluded that the prevalence of familial microtia is over 20 %. This finding was based on 
the patient questionnaire. The majority of the relatives were not examined by the author(s). 
As microtia is very visible and confusing, information given by the patients or their parents 
can be considered true. Minimally abnormal ears, such as skin tags and Marx grade I 
microtia, may be overlooked and thus the actual proportion of familial microtia may be 
even greater.  
 
The majority of previous reports suggest that there is a hereditary form of microtia with an 
autosomal dominant mode of inheritance with variable expression and incomplete 
penetrance (Mastroiacovo et al. 1995, Chafai Elalaoui et al. 2010). In addition, autosomal 
recessive modes have been scarcely reported (Konigsmark et al. 1972, Llano-Rivas et al. 
1999).  
 
In most studies, the possibility of multigenic inheritance is suggested. A single gene 
mutation causing microtia has not been identified, though microtia is a clinical finding in 
many known single gene syndromes or disorders. It is possible that a gene or some genes 
interact with environmental factors and that this co-operative action causes microtia. 
 
As with other populations, the mode of inheritance of microtia in the Finnish population 
seems to be autosomal dominant with incomplete penetrance in the majority of the 
families. Some typical features of autosomal dominant inheritance are present: fairly even 
expression of microtia in men and women, frequent expression in siblings and frequent 
expression in successive generations. In our study, multigenic inheritance cannot be 
excluded. 
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The genetic isolation and genetic bottlenecks of the Finnish population have led to a 
unique “genetic pool”. Bottleneck can be described as a remarkable reduction in the size 
of a population. The result is a decrease in the gene pool of the population. War, 
starvation and environmental catastrophes may cause genetic bottlenecks, for instance. A 
founder effect occurs when a small subset of a large population has been genetically 
isolated. This new small "founder" population has less genetic variation than the original 
population leading to enrichment of some alleles and lack of others. This is demonstrated 
by the Finnish disease heritage: some genetic diseases are enriched in Finland and others 
are extremely rare in the Finnish population due to the genetic features of the Finnish 
founder population. A common distant ancestor is often shared with regard to the diseases 
of Finnish heritage. We tried to identify a founder effect by analyzing the birthplaces of 
grandparents of microtia patients. Concentration around particular places would have 
suggested the presence of a common ancestor. In our study the birthplaces of parents or 
grandparents of familial and sporadic microtia patients were rather evenly distributed. No 
founder effect was identified. This can be due to genetic heterogeneity or an ancestor so 
distant that it could not be identified. 
 
In our study, we compared the phenotypic differences between the familial and sporadic 
microtia patients. In the statistical analysis there were no significant differences, except for 
that familial microtia patients had more urinary tract anomalies than sporadic cases. This 
difference was statistically significant (P=0.01), but the sample size was small (3/22 versus 
0/79) and the finding must be interpreted with caution. 
 
The knowledge of the gross proportion of familial, non-syndromic microtia cases in Finland 
is valuable information for the patients and their parents. Microtia is definitely a dramatic 
condition and questions concerning the hereditary nature of this condition are important. 
On the basis of this study, we can estimate the gross magnitude of familial microtia in 
Finland. 
 
6.3 Surgical reconstruction of the auricle 
 
In most studies concerning the reconstruction of the auricle, the procedure is characterized 
by the words challenging, difficult or complex. The process through which you have to 
create a three-dimensional, immunocompetent, aesthetically acceptable and durable 
auricle deserves those definitions. 
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The term “learning curve” is used to describe a phenomenon where repetition of a task 
leads to improvement in performance over time. If the task is rather simple, such as 
myringotomy, improvement is supposed to be fast in the beginning and a steady state is 
reached quickly. If the task is complex, like auricular reconstruction, improvement is 
supposed to be slow and steady outcomes may be reached within many years. In addition, 
if the surgical procedure is complex, there may be evolution of the procedure and 
therefore the learning may occur more rapidly or begin to slow down. 
 
We studied the learning curve of a single surgeon performing the reconstruction of the 
auricle. The object of the learning process was the aesthetic result and this was evaluated 
by a panel consisting of six physicians. In the same study, patient satisfaction was 
evaluated. All 51 patients in the study were non-syndromic, their microtia grade was Marx 
III and all cases were unilateral. These inclusion criteria enabled us to study patient 
material that was as coherent as possible. For example, syndromic facial features or 
severe hemifacial microsomia would have distorted reliable evaluation of the aesthetic 
result. In Marx grade III (lobulus-type) microtia, a customized style of reconstruction is 
required and it is supposed to have a specific learning curve. Unilaterality was one 
criterion that made comparison between the result and the unaffected auricle possible. 
 
According to our study, the learning curve in microtia surgery is long and gentle. This is 
consistent with the hypothesis that in complex surgery, an extended training period is 
required. It is not just the total scope of the operation, but also the frequency that is 
supposed to have an influence on learning. The surgeon who made all the ear 
reconstructions in our study had done less than 10 operations per year in the beginning 
and handled 20 new cases a year in the later period in the studied time sequence, which 
was from 1998 to 2006. There was a statistical plateau in the outcomes from operation 20 
to 40. Thereafter, a new period of improvement started and at the endpoint of the study 
there still seemed to be a trend towards improvement in the outcomes. The possible 
explanation for this improvement is the increase in the frequency of the operations. 
Including all ear reconstructions the overall volume was 124 during the studied period of 
time. This volume plus other soft-tissue surgery are supposed to have positive effect on 
learning. 
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The first stage was done according to the basic Nagata technique. The cartilage was 
taken from sixth to eighth rib. In the first stage, the costal cartilage was harvested, the 
auricular frame was constructed and then placed under the skin flaps. In early cases the 
subcutaneous pedicle in the concha region was omitted, but as skin edge necrosis at the 
distal edge of the flap was common, the pedicle was used in later cases. In the second 
stage, the cartilage graft that was used as a wedge was placed behind the pinna to give 
support to the protrusion. This cartilage was covered with a retroauricular fascial flap and a 
split skin graft taken from the scalp with dermatome.  
 
The assessment of the surgical results was done by the panel of six physicians and the 
patient’s self-assessement group. The findings that support the reliability of the evaluation 
method used in our study are: 1. high intraclass correlation (0.90) and 2. the mean of 
points given by the self-assessment group (6.91) and the mean given by the physicians for 
the corresponding patients (6.59) were rather similar. 
Twenty-two patients did a self-evaluation of their reconstructed auricle. Female patients 
were more critical and gave fewer points than males. This difference was statistically 
significant. The age of the patient did not affect the evaluation. This self-assessment group 
is rather small and the results should be interpreted with caution.  
 
There are previous learning curve studies where rather objective variables are measured. 
Moffat et al. (1996) studied facial nerve outcome in 300 patients undergoing vestibular 
schwannoma surgery. They found major improvement between the first and second series 
of 50 patients. Aural atresia surgery has been studied and the main outcomes were 
hearing results and complication rate (Patel and Shelton 2007). Hearing results have been 
the measured objective in a learning curve study concerning stapedotomy (Sargent 2002). 
Operation time, complication rate and hearing results are key objectives to be measured. 
According to our study, the outcomes of aesthetic surgery can also be assessed reliably 
using reasonable technical arrangements. 
 
Microtia reconstruction with the use of autogenous rib cartilage is difficult. Learning and 
perfecting the procedure happens over the long-term and it may be accelerated by 
increasing the frequency with which operations are performed. Based on this finding, I 
would dare to suggest that auricle reconstruction should be performed from a centralized 
location in order to secure acceptable quality. In addition, an apprentice should be 
recruited well in advance if continuity of the reconstructive surgery of the auricle is an 
! 59!
issue. Microtia reconstructions are predominantly performed by a plastic surgeon in 
Finland. Both otologic surgeons and plastic surgeons do microtia operations worldwide. 
Good soft-tissue fingering and sense of aesthetics are valuable properties regardless of 
the background of the surgeon.  
Visits to and co-work with an experienced colleague may be helpful in the learning 
process. The surgeon in our study was in collaboration with a high-volume surgeon F. 
Firmin and gained good basic training in the beginning of his learning curve (Firmin, 1998).  
As with surgery in general, preoperative patient information is important and criticism by 
females may be useful for the surgeon to know when planning auricular reconstruction. 
 
6.4 Treatment options in auricular reconstruction 
 
Auricular reconstruction with autogenous rib cartilage is a widely accepted and preferred 
method. The patient’s own tissue is definitely biocompatible and a successfully 
reconstructed auricle is durable. Yet there are still some drawbacks, such as scarring and 
temporary pain in the donor site. Difficult and multi-stage surgery that is connected with a 
long learning curve is also a relative drawback of this well-established technique. There 
are alternative solutions to the rib cartilage technique. 
 
The Medpor TM is a high-density porous polyethylene (PPE) material that has been used in 
craniofacial surgery since the 1990’s. Auricular prosthesis made of PPE has been used 
worldwide and nowadays the complication rate may be acceptably low in experienced 
hands (Romo T 3rd et al. 2009, Reinisch et al. 2009). Advantages of the Medpor TM include 
the ability to operate on a younger child so that rib cartilage growth does not have to be 
waited for, avoidance of chest incision, decreased operation time and ease of use 
compared to meticulous sculpturing of the cartilage. A possible negative reaction to foreign 
material, sensitivity to infections and the durability of the implant are debatable drawbacks. 
Reinisch et al. (2009) have a large amount of patient material and long follow up cases 
spanning up to 18 years. The problems they had in the early years, like fractures of the 
frame and exposures, were minimized through the evolution of the procedure. The frame 
design has undergone design changes and is stronger nowadays. In addition, the covering 
of the frame with temporoparietal fascia (TPF) and the underlying subgaleal fascia (SGF) 
has diminished the rate of frame exposures. They have also started to do single stage 
procedures. Their total amount of auricular reconstruction with Medpor TM has been 786, 
as reported in 2009. Rheinish states that the presence of an ipsilateral bone-anchored 
! 60!
hearing aid or previous failed auricular reconstruction are not obstacles for the success of 
their technique based on PPE frame and TPF+SGF covering.  
 
Ear epithesis (or synonymously prosthesis) is another choice instead of rib cartilage 
reconstruction. The best practice is the use of osseointegration of the epithesis. Fixation 
with adhesives is less secure and more messy. There is a long tradition and extensive 
experience with the use of ear epitheses in Sweden. A. Tjellström is a pioneer in this area 
and he has been using osseointegration for over three decades (Tjellström et al. 1981). In 
their studies, high patient satisfaction and low complication rates have been achieved 
(Westin et al. 1999). In addition to the surgeon successfully implanting the titanium fixation 
into the skull, a skilled artist called an anaplastologist is needed. The coloring of the 
epithesis should be appropriate and must be adjusted to the surrounding skin. The role of 
a skilled Anaplastologist is important and such a professional should be available when 
planning the implantation of an ear epithesis.  
 
The indications for autogenous rib cartilage reconstruction versus epithesis are outlined in 
a comprehensive and inclusive report by Thorne et al. (2001). They gathered the following 
relative indications for prosthetic reconstruction based on their experience: 1. failed 
previous cartilage reconstruction, 2. severe soft-tissue and/or skeletal hypoplasia, for 
example serious hemifacial microsomia, 3. a low or unfavorable hairline and, 4. 
posttraumatic or ablative auricular defects. The disadvantages of the prosthesis include: 
replacement of the prosthesis every 2 to 5 years for life, attention of the transcutaneous 
abutment, the patient must remember to put the prosthesis in place every day, and the 
possibility of breakage or loss. They conclude that the primary indication for prosthetic 
reconstruction is an acquired auricular defect, generally in an adult patient. 
 
It can be concluded that autogenous rib cartilage reconstruction is the preferred method 
over ear episthesis. However, the advantages and disadvantages of both methods should 
be discussed with the patient and their parents. 
 
 
Replacement of damaged or missing structures of the human body by biological tissue-
engineered materials is possible nowadays. Auricular cartilage can be manufactured by 
means of tissue-engineering. The desirable advantages of tissue-engineering could be 
avoidance of donor site morbidity in the rib cartilage area and avoidance of challenging 
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and time consuming sculpting of the auricular frame. The method that is used by Yanaga 
et al. (2009) includes: 1. the surgical harvesting of the tissue-engineered cartilage block 
from the abdominal subcutis, 2. sculpturing of the auricular frame from that block. Thus, in 
their method, neither of the advantages are actualized. The fabrication of the auricular 
frame is an important step that may have an influence on the look of the reconstructed ear. 
In addition, just like with a PPE frame, the handling of the skin flaps and fascias may 
significantly affect the final appearance.  
Adipose-derived stem-cells are used for regenerative purposes, in particular following 
surgery for breast cancer. Some authors suggest that tissue-engineered grafting 
procedures may predispose the patient to the recurrence of breast cancer (Chandler et al. 
2012). This possible risk is worth recognizing even though the breast cancer prone 
humans are not directly comparable with microtia patients and the use of cartilage for 
reconstruction. Tissue-engineered auricular cartilage may be a good choice in the future if 
the manufacturing process could be done without surgery and hand sculpting of the frame. 
In addition, the safety with regards to the possibility of neoplasia should be confirmed. So 
far, reconstruction with human rib cartilage is superior. 
 
 
6.5 Auricular malformations and orofacial clefts 
 
The incidence of auricular malformations among patients with cleft lip or cleft palate are 
reported to be 0.6-2 % (Hartung et al. 1973, Lilius 1992). There is only a small amount of 
reported data on the association of these malformations. The lips and the palate are 
derived from the first pair of pharyngeal arches. As well, the external and middle ear arise 
mainly from the first and second pharyngeal arches and the pharyngeal clefts and 
pouches are in between them. Differentiation of these structures begins in the 5th and 6th 
gestational week. Due to embryogenesis, it is supposed that orofacial clefts may be 
concurrently expressed with malformations of the external and the middle ear. We 
conducted detailed and systematic research on these possibly coincidental 
malformations. 
 
We found one hundred patients with cleft lip or palate and a malformed auricle. One focus 
was whether there is a specific auricular malformation associated with a certain cleft type. 
In our cleft patient material, the prevalence of microtia increased as the severity of cleft 
increased from cleft lip through cleft lip and alvelous to cleft lip and palate. This trend was 
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not present among patients with cleft palate only. Microtia was present in 43% of the cleft 
patients and it seems to be the most common ear malformation and skin tag was present 
in 15% of the patients. Some bias may be present because the diagnosis of microtia is 
definite, while skin tags may be overlooked and underreported. In addition, there is no 
objective and evident line between protruding and normal auricles. The prevalence of 
microtia among cleft patients is approximately 5/1000, which is significantly more than the 
prevalence of microtia in the whole Finnish population (4.3/10 000). This is not surprising, 
because the orofacial structures are derivatives of the first pharyngeal arches and the 
auricles arise from the first and the second pharyngeal arches. However, the exact 
pathogenesis of these malformations remains unknown. 
 
Some limitations were present in our analyses. Informative photographs of the auricles 
were available for 62% (62/100) of the patients. In the remaining 38 patients, our 
classification of the ear malformation was based on written explanations of ear 
deformities. To avoid misconceptions, only unequivocal cases were included in this study. 
In the beginning of the study, we had 122 patients, but 22 patients were excluded on the 
basis of unclear or missing information in the hospital charts. In addition, the subgrouping 
of clefts and ear deformities was essential, but it resulted in small sample sizes and 
statistical strength was diminished. The number of observations in each group was too 
small to prove the differences statistically.  
 
Even if our material constituted the largest report on associations of auricular 
malformations and clefts, the findings were not statistically significant and we could not 
affirm the hypothesis that the severity of the cleft correlates with the severity of the ear 
malformation. Almost all cleft patients are included in the cleft register and it is impossible 
to arrange a more inclusive study in Finland. To test the increasing prevalence of microtia 
in relation to the severity of cleft, an international multi-center study with a larger amount of 
patient material should be conducted. 
 
 
6.6 The role of imaging 
 
The value of routine imaging with HRCT or MRI (magnetic resonance imaging) is 
debatable. However, imaging can reveal anomalies of great importance when planning 
middle ear and external ear canal surgery in microtia patients.  
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If the external ear canal is atretic, abnormal skin growth into the middle ear or mastoid 
area is not assumable and the development of cholesteatoma is hindered. In our material, 
only two patients of 190 were reported to have cholesteatoma. It is possible that all 
cholesteatomas were not reported, but still it seems to be infrequent. Cole et al. (1990) 
reviewed over 600 patients with major congenital ear malformations. In their material, 50 
patients (8.3%) had congenital aural stenosis. In patients 12 years and older with a 
stenosis of 2 mm or less, cholesteatoma was present in 91% percent of their ears. In this 
study, cholesteatoma seemed to appear slowly and was particularly associated with ear 
canal stenosis. 
 
On the basis of the literature and our own patient material, imaging on a routine basis 
should be avoided and used only when necessary for the diagnosis or treatment of the 
disease. Those microtia patients with external auditory canal stenosis should be placed in 
follow up and cholesteatoma should be suspected if typical symptoms or signs are 
present, such as pain and recurrent external ear canal discharge. In suspicious cases, 
HRCT is recommended. 
 
 
6.7 Hearing restoration surgery 
 
In bilateral microtia hearing restoration by surgery should be considered. The decision is 
mainly based on the Jahrsdoerfer grade (1992). With a Jahrsdoerfer atresia score of 
seven or more (on a scale of 1-10), the chance of successful surgical hearing restoration is 
good. Stilianos et al. (1995) stated that in Marx grade III microtia, the atresia score is 5.9 
on average. Patel et al. (2007) retrospectively studied 64 aural atresia patients and stated 
that a learning curve of at least 48 operations was required to reach stable long-term (>1 
year) hearing results. The mean long-term postoperative air-bone gap (ABG) was 26.7 dB 
HL. All the operations were done during a ten-year period at a tertiary referral center. In 
the entire group 38% of patients achieved good hearing (speech reception treshold of < 30 
dB, speech discrimination score > 70%). In the last group of 16 operation the percentage 
was 56, which means improvement in hearing results. 
In our material, the proportion of Marx grade III is almost 60%. With 11.5% bilaterality and 
based on this, only 5% of microtia patients in Finland would be candidates for hearing 
restoration surgery. This leaves us with one or two patients per year, which strongly 
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supports national centralization of auricular surgery in Finland. Systematic review of the 
hearing results of the hearing restoration surgery in Finland is not available and it should 
be organized. 
 
An interesting question is whether to operate on ears with unilateral conductive hearing 
loss and if so, what is a sensible target level of reception thresholds. In a study by Lieu 
(2004), school-age children with unilateral hearing loss (UHL) appear to have increased 
rates of grade failures. They also needed additional educational assistance and they were 
seen as having behavioral difficulties in the classroom. Speech and language delays may 
occur in some children with UHL, but it can be temporary. In a recent study by Lieu et al. 
(2012), children with UHL demonstrated improvement in oral language verbal skills over 
time during follow-up, but did not demonstrate improvements in school performance. They 
recommended individual education plans as a solution. Unilateral hearing preservation 
surgery (or hearing aid) was not mentioned in the conclusion.  
 
Hearing restoration surgery for reasons other than atresia of the external ear canal is 
easier to justify for anatomic reasons. Stapes surgery or standard tympanoplasty are also 
performed on a regular basis with unilateral conductive hearing loss. With a normal 
external ear canal and a mostly normal middle ear, achieving satisfactory postoperative 
hearing results is realistic. It is also likely that regular and frequent ear surgery yields 
better results. Because of the low frequency of operations and long learning curve, hearing 
restoration surgery should be avoided in aural atresia if contralateral hearing is normal. 
This conception is supported by the low frequency of good hearing results (38-56%) in a 
high-volume center ( Patel et al., 2007). 
 
Bilateral microtia is a challenge because these patients require both reconstruction of the 
auricle and rehabilitation of hearing. If hearing restoration surgery is planned, it is 
recommended to be done after the auricular reconstruction. The main reason is scarring of 
the soft tissues that may make the reconstruction more difficult. However, patients with 
bilateral microtia and hearing impairment cannot wait until the age of nine to ten. Three 
possibilities are available: 1. a conventional air conduction hearing aid, if the anatomy is 
favorable, 2. a bone conduction hearing aid without bone anchoring, 3. a bone-anchored 
hearing aid that is fixed 6-7 cm behind the pinna. A bone-anchored hearing aid that is fixed 
was recommended in a small study by Bajaj et al. (2005).  
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Alternative hearing devices without a skin-penetrating material are also available. These 
transcutaneous applications may cause less scarring and could be a choice for microtia 
patients even before the reconstruction of the auricle. 
 
 
6.8 Audiological aspects 
 
Otoacoustic emissions and auditory brainstem responses are used for newborn hearing 
screening. If the test result is normal for the non-affected ear of a newborn with microtia, 
no additional testing is routinely carried out.!
The auricle and the external ear canal are usually abnormal in microtia and the use of a 
conventional hearing aid is impossible. Instead, percutaneous bone-anchored hearing aids 
are practical.  
A hearing aid is justifiable in bilateral microtia, but debatable in unilateral microtia. There 
are several studies with pros and cons. A bone-anchored hearing device (or BAHA®, 
bone-anchored hearing aid, registered trademark is owned by Cochlear) head band is a 
valuable tool for preoperative evaluation. It is like a tennis player’s sweatband that slightly 
compresses the device against the skull. Kunst et al. (2008) studied 20 patients with 
congenital unilateral conductive hearing impairment. They conclude that some patients 
have good directional hearing and speech-in-noise scores even without a BAHA®. Six of 
the patients did not show any significant improvement after a hearing device implantation. 
However, compliance with BAHA® use in the whole patient group was high. The 
proportion of patients using a bone-anchored hearing device 4-7 days/week was 80% and 
7 days/week 55%. In the consensus statement on the bone-anchored hearing device by 
Snik et al. (2005), it was advised to provide the patient with a head band for a trial period 
of at least 2 weeks when planning a BAHA® fitting for the patients with unilateral 
conductive hearing loss. A positive reaction to the trial BAHA® is the most valuable 
prognostic factor during the preoperative workup. They also conclude that bone-anchored 
hearing device results are superior to those obtained with conventional bone conduction 
devices. The bone-anchored hearing system should be seen as the first choice when a 
bone conduction device is the right solution. In bilateral cases, audiological results are 
better with a bilateral fitting. It is recommended to implant one bone-anchored hearing 
device  and pretest the second with a head band before possible surgery. If a bone-
anchored system is assembled, the operation should be done after the auricular 
reconstruction or the bone-anchoring should be fixed 6-7 cm behind the pinna. A bone-
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anchored hearing device is applicable for both conductive and sensorineural hearing 
impairment. 
 
In our material, all patients with a BAHA® had bilateral microtia (not reported in our 
original publication). One patient is using a BAHA® bilaterally. Referring to the literature, 
we could more actively consider bilateral implantation of bone-anchored hearing device. 
Both in unilateral and bilateral microtia, pretesting with a head band is recommended. This 
pretesting mode is also applied at Helsinki University Hospital. The new innovations of 
transcutaneous devices, which can be used through the intact skin, have been introduced 
recently and can be utilized among microtia patients. 
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7. Conclusions 
 
 
There is variation in the prevalence and characteristics of microtia in different populations. 
The register based prevalence of microtia in Finland is almost double compared to the 
overall global prevalence. 
 
The prevalence of familial microtia in the Finnish population is higher than 20%. The 
sporadic and familial microtia patients do not differ significantly. The pattern of inheritance 
seems to be autosomal dominant with incomplete penetrance. 
 
The learning curve with microtia reconstruction surgery is long. Surgical centralization and 
long-term trainee arrangements are advisable. The results of reconstructive surgery and 
aesthetic results can reliably be rated by an evaluation panel. 
 
Microtia seems to be the most common auricular malformation among cleft patients. The 
prevalence of microtia seems to increase as the severity of cleft lip increases, whereas in 
isolated cleft palate, microtia seems to occur independently from the grade of cleft. 
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Appendix 
The patient questionnaire, which constituted the basis for the patient based information in 
studies I and II. 
 
 
      Mikrotia 1-06 
 
Ulkokorvan kehityshäiriöt – tietoa tutkimuksesta 
 
Otamme teihin yhteyttä, koska Teitä / lastanne on tutkittu HYKSin Huuli- ja 
suulakihalkiokeskuksessa (HUSUKE) ulkokorvan kehityshäiriön vuoksi. HUSUKEssa ja HYKSin 
Korvaklinikalla on vuonna 2006 alkanut tutkimus, jonka tavoitteena on selvittää ulkokorvan 
kehityshäiriöiden syntymekanismeja, ominaispiirteitä ja perinnöllisyyttä. 
Tämä kyselykaavake on lähetetty noin 200 HUSUKEssa tutkitulle henkilölle. Kaikki vastaukset ja 
näytteet ovat täysin luottamuksellisia, eikä niitä tulla missään olosuhteissa luovuttamaan 
tunnistettavassa muodossa tutkimusryhmämme ulkopuolelle. Koska keskitymme kehityshäiriöiden 
perusmekanismien selvittelyyn, on todennäköistä, että ette henkilökohtaisesti hyödy tutkimukseen 
osallistumisesta. Korostamme, että tutkimukseen osallistuminen on täysin vapaaehtoista, eikä 
osallistuminen tai osallistumatta jättäminen millään lailla vaikuta hoitoonne. Tutkimuksen 
onnistumisen kannalta olisi kuitenkin erittäin suotavaa, että mahdollisimman moni siihen 
osallistuisi. 
Vastatessanne tähän kyselyyn, annatte samalla suostumuksenne tutkimukseen osallistumisesta. 
Vastatkaa kyselyyn mahdollisimman tarkasti, käyttäen selkeää käsialaa. Mikäli ette tiedä vastausta 
johonkin kysymykseen niin jättäkää kyseinen kohta tyhjäksi. Palauttakaa kyselykaavake oheisessa 
palautuskuoressa. Mikäli teillä on kysyttävää tutkimuksen osalta voitte ottaa meihin yhteyttä 
puhelimitse tai sähköpostitse: 
 
 
Lääkäri Jorma Rautio, HYKS HUSUKE 
Lääkäri Tuomas Klockars, HYKS Korvaklinikka
 
Ulkokorvan kehityshäiriöt – Kyselykaavake   mikrotia1-06           
 
NIMI:__________________________________________________________________________ 
SYNTYMÄAIKA:_________________________________________________________________ 
1) Syntymäpainonne?_________________________________________________   En tiedä 
2) Syntymäviikot (ts. täysiaikainen vai keskonen)?___________________________    En tiedä 
3) Oliko äidillänne raskausaikana ongelmia?      Kyllä        Ei        En tiedä 
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(Esim. raskaudenaikainen sokeritauti, raskausmyrkytys, vakavia tulehduksia)? 
Mikäli kyllä, mitä?_______________________________________________________________ 
4) Nykyinen pituus: ___________________________ paino: ___________________________ 
5) Oliko lapsuutenne/nuoruutenne kasvu ja kehitys normaalia?     Kyllä        Ei        En tiedä 
6) Minkä ikäisenä tuli ensimmäiset sanat: __________________, kävely: __________________ 
7) Normaali kansa- / peruskoulu?    Kyllä        Ei Erityisluokka?    Kyllä        Ei 
8) Onko teillä sydänsairauksia tai sydämen kehityshäiriöitä?    Kyllä        Ei 
Mikäli kyllä, mikä? _____________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?______________________________ 
9) Onko teillä ihon sairauksia?      Kyllä        Ei 
Mikäli kyllä, mikä? _____________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?______________________________     
10) Onko teillä hengityselinten/keuhkojen sairauksia?     Kyllä        Ei 
Mikäli kyllä, mikä? _____________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?______________________________  
11) Onko teillä munuaisten, virtsateiden tai sukuelinten sairauksia?    Kyllä        Ei 
Mikäli kyllä, mikä? _____________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?______________________________ 
12) Onko teillä raajojen sairauksia tai kehityshäiriöitä?    Kyllä        Ei 
Mikäli kyllä, mikä? _____________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?______________________________ 
13) Onko teillä luuston, nivelten tai selkärangan sairauksia?    Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
14) Onko teillä hiuksien, kynsien tai hampaiden sairauksia?    Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
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15) Onko teillä silmien, aivojen tai hermoston sairauksia?    Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
16) Onko teillä sisäelinten tai ruuansulatuskanavan sairauksia?    Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
17) Onko teillä psyykkisiä sairauksia (esim. masennus)?    Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
18) Onko teillä  hormoni / aineenvaihdunnan sairauksia?    Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
19) Onko teillä  jokin muu sairaus/kehityshäiriö?     Kyllä        Ei 
Mikäli kyllä, mikä? _______________________________________________________________ 
Onko jollakin suvussanne sama sairaus?    Kyllä, kenellä?________________________________ 
20) Onko teillä jokin säännöllinen lääkitys?      Kyllä        Ei 
Mikäli kyllä, mikä?___________________________________________________________ 
21) Onko jollakin suvussanne teidän lisäksenne korvalehden kehityshäiriö?    Kyllä 
(Esim. epänormaali tai puuttuva korvalehti) 
Mikäli kyllä, kenellä? ___________________________________________________________ 
22) Onko jollakin suvussanne korvan lähialueen/kasvojen kehityshäiriö?    Kyllä 
(Esim. poikkeava ihon aukko tai poimu, huuli- suulakihalkio) 
Mikäli kyllä, kenellä? ___________________________________________________________ 
23) Onko suvussanne jokin perinnöllinen sairaus?     Kyllä        Ei 
Mikäli kyllä, mikä?_____________________________________________________________ 
24) Onko teillä sisaruksia?     Kyllä. Veljiä________ kpl, siskoja ________ kpl  
25) Onko teillä lapsia?     Kyllä. Poikia ________ kpl, tyttöjä ________ kpl  
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26) Onko vanhemmillanne sisaruksia? 
   Kyllä. Äidin siskoja____, äidin veljiä______, isän siskoja______, isän veljiä ______ 
27) Onko teitä tutkinut korvan kehityshäiriön vuoksi 
Korvalääkäri?       Kyllä        Ei        En tiedä 
Mikäli kyllä, missä?_______________________________________________________________ 
Lastenlääkäri?       Kyllä        Ei        En tiedä 
Mikäli kyllä, missä? ______________________________________________________________ 
Perinnöllisyyslääkäri?       Kyllä        Ei        En tiedä 
Mikäli kyllä, missä? ______________________________________________________________ 
28) Onko teille tehty kuvantamistutkimuksia (esim. röntgen, ultraääni, magneettitutkimus)? 
Korvien/ pään tietokonekuvaus?     Kyllä, missä?__________________________________ 
Kasvojen tai hampaiden röntgen?     Kyllä, missä?__________________________________ 
Muita tutkimuksia? Mikä ja missä?___________________________________________________ 
29) Saammeko pyytää sairauskertomustietojanne muista sairaaloista, terveyskeskuksista yms.? 
   Kyllä        Ei 
30) Arvioi leikatun korvasi ulkonäkö käyttäen pisteytystä 1-10 (1 täysin kelvoton – 10 täydellinen): 
_________ pistettä.   Jos korvaa ei ole leikattu jätä kohta tyhjäksi.   
31) Saammeko ottaa teihin yhteyttä mahdollisten lisäkysymysten tai jatkotutkimuksien osalta? 
   Kyllä        Ei 
   Puhelimitse, nro ___________________________, klo ____________________ 
   Sähköpostitse, osoitteseen __________________________________________ 
 
 
_______________ ___________________________________________ 
Päiväys  Allekirjoitus (tarvittaessa huoltajan) 
  ____________________________________________ 
  Nimenselvennys 
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